Segra Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $1.82M

  • Investors
  • 2

Segra General Information

Description

Operator of a biotechnology company intended to accelerate the advancement of the cannabis industry. The company specializes in industrial-scale plant micropropagation, focusing on plant-based medicines, including medicinal cannabis, genetics, and cultivation techniques to produce healthy and consistent plant material for cultivation and research purposes, enabling researchers to develop medicines for treating medical conditions like depression, anxiety, chronic pain, and insomnia.

Contact Information

Website
www.segra-intl.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 21300 Gordon Way
  • Suite 108
  • Richmond, British Columbia V6W 1M2
  • Canada
+1 (604)
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Cannabis, AgTech, Supply Chain Tech
Corporate Office
  • 21300 Gordon Way
  • Suite 108
  • Richmond, British Columbia V6W 1M2
  • Canada
+1 (604)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Segra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 18-Nov-2022 $1.82M Completed Generating Revenue
9. Debt - General 01-Feb-2022 Completed Generating Revenue
8. Later Stage VC 22-Apr-2021 Completed Generating Revenue
7. Later Stage VC 30-Dec-2020 Completed Generating Revenue
6. Later Stage VC 15-Apr-2020 Completed Generating Revenue
5. Later Stage VC 24-Oct-2019 Completed Generating Revenue
4. Early Stage VC 01-Oct-2018 Completed Generating Revenue
3. Merger/Acquisition 10-Sep-2018 Cancelled Generating Revenue
2. Angel (individual) 30-Jul-2018 $7.2M $7.2M Completed Generating Revenue
1. Reverse Merger 29-Oct-2015 $380K Cancelled Startup
To view Segra’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Segra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to accelerate the advancement of the cannabis industry. The company special
Other Pharmaceuticals and Biotechnology
Richmond, Canada
28 As of 2026

Seattle, WA
 

Santa Fe, NM
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Segra Competitors (2)

One of Segra’s 2 competitors is Verda Bio, a Venture Capital-Backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verda Bio Venture Capital-Backed Seattle, WA
Trait Biosciences Venture Capital-Backed Santa Fe, NM
You’re viewing 2 of 2 competitors. Get the full list »

Segra Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Segra Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022115850-A1 Tissue culture of an autoflower cannabis plant Inactive 24-Nov-2020

Segra Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Segra Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
SSC Advisors Venture Capital Minority
Altitude Investment Management Venture Capital Minority
To view Segra’s complete investors history, request access »

Segra Acquisitions (1)

Segra’s most recent deal was a Merger/Acquisition with Klonetics. The deal was made on 20-May-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Klonetics 20-May-2025 Merger/Acquisition Cultivation
To view Segra’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Segra Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Klonetics Kelowna, Canada 2018

Segra FAQs

  • When was Segra founded?

    Segra was founded in 2014.

  • Where is Segra headquartered?

    Segra is headquartered in Richmond, Canada.

  • What is the size of Segra?

    Segra has 28 total employees.

  • What industry is Segra in?

    Segra’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Segra a private or public company?

    Segra is a Private company.

  • What is Segra’s current revenue?

    The current revenue for Segra is .

  • How much funding has Segra raised over time?

    Segra has raised $27.8M.

  • Who are Segra’s investors?

    SSC Advisors and Altitude Investment Management have invested in Segra.

  • Who are Segra’s competitors?

    Verda Bio and Trait Biosciences are competitors of Segra.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process